Peter Collins

Director Ejecutivo en CELLBXHEALTH PLC .

Fortuna: 144 900 $ al 31/05/2026

67 años

Health Technology

Distribution Services

Health Services

Perfil

Peter Michael Collins is the founder of European Personalised Medicine Association.
Mr. Collins is Chief Executive Officer & Director at CelLBxHealth Plc since 2026.
Mr. Collins was Chief Executive Officer at SAGA Diagnostics AB. Mr. Collins was Director & Chief Commercial Officer at Yourgene Health Ltd. Mr. Collins was Vice President & Head-Diagnostics at GSK Plc.
Mr. Collins was Principal at Riverside Biosciences Ltd., BioGenex Laboratories, Inc., Gentronix Ltd., and Pronostics Ltd. Mr. Collins was Senior Vice President-Pharma Business Development at DxS Ltd. Mr. Collins was Vice President-Marketing & Sales at Abbott Molecular Diagnostics.
Mr. Collins was Vice President-Pharma Business Development at QIAGEN Ltd.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
CELLBXHEALTH PLC 0,44 %	18/12/2025	5.000.000 ( 0,44 % )	144 900 $	31/05/2026

Cargos activos de Peter Collins

Empresas	Cargo	Inicio
CELLBXHEALTH PLC	Director Ejecutivo	16/10/2025

Todos los cargos activos de Peter Collins

Antiguos cargos conocidos de Peter Collins.

Empresas	Cargo	Fin
YOURGENE HEALTH	Director/Miembro de la Junta	01/11/2018
SAGA Diagnostics AB SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance	Director Ejecutivo	-
GSK PLC	Corporate Officer/Principal	-
Qiagen Ltd. Qiagen Ltd. Medical/Nursing ServicesHealth Services Engages in other human health activities	Corporate Officer/Principal	-
European Personalised Medicine Association	Fundador	-

Ver el detalle de la experiencia de Peter Collins.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Peter Collins.

Empresas relacionadas

Empresas privadas	12
CelLBxHealth Plc CelLBxHealth Plc Medical DistributorsDistribution Services Operates as a holding company with interests in providing products in cancer diagnostics and foetal health	Distribution Services
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
Riverside Biosciences Ltd. Riverside Biosciences Ltd. Medical SpecialtiesHealth Technology Produces neo natal blood testing kits	Health Technology
BioGenex Laboratories, Inc. BioGenex Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Provides solutions for automation of cell and tissue testing	Health Technology
Gentronix Ltd. Gentronix Ltd. BiotechnologyHealth Technology Provides services and solutions to help organizations optimize the development of drugs and other chemicals	Health Technology
Pronostics Ltd. Pronostics Ltd. Pharmaceuticals: MajorHealth Technology Provides and develops diagnostic test for heart disease	Health Technology
DxS Ltd. DxS Ltd. Medical SpecialtiesHealth Technology Develops and manufactures molecular diagnostics products	Health Technology
Abbott Molecular Diagnostics
Qiagen Ltd. Qiagen Ltd. Medical/Nursing ServicesHealth Services Engages in other human health activities	Health Services
European Personalised Medicine Association
Yourgene Health Plc Yourgene Health Plc Medical SpecialtiesHealth Technology Develops molecular diagnostic products	Health Technology
SAGA Diagnostics AB SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance	Health Technology